Explore more publications!
Alabama STEM News
Submit Press Release

Alabama STEM News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Alabama STEM News.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on October 6, 2025

Eagle Pharmaceuticals Announces Availability of Unaudited First Quarter 2025 Financial Statements
October 6, 2025

Eagle Pharmaceuticals Announces Availability of Unaudited First Quarter 2025 Financial Statements

Indeterminate GlobeNewswire
Ryoncil® Revenues Increase 66% in Second Quarter Post Launch
October 6, 2025

Ryoncil® Revenues Increase 66% in Second Quarter Post Launch

Indeterminate GlobeNewswire
Qualigen Therapeutics (NASDAQ: QLGN) Announces Executives, Board of Directors Appointments and Auditor Transition
October 6, 2025

Qualigen Therapeutics (NASDAQ: QLGN) Announces Executives, Board of Directors Appointments and Auditor Transition

Indeterminate GlobeNewswire
Court Dismisses Key Fraud Allegations in LuxUrban Securities Case, Leaving Narrow Disclosure Dispute According to New Stanford Legal Report
October 6, 2025

Court Dismisses Key Fraud Allegations in LuxUrban Securities Case, Leaving Narrow Disclosure Dispute According to New Stanford Legal Report

Indeterminate GlobeNewswire
Parler Cloud Technologies and Kyvo Launch Global “Invite & Earn” Program — Rewarding Users and Their Referrals with 500 OPT Tokens Each
October 6, 2025

Parler Cloud Technologies and Kyvo Launch Global “Invite & Earn” Program — Rewarding Users and Their Referrals with 500 OPT Tokens Each

Indeterminate GlobeNewswire
Dyne Therapeutics Announces Additional One-Year Clinical Data Demonstrating Functional Improvement from Phase 1/2 ACHIEVE Trial of Zeleciment Basivarsen (DYNE-101) for Myotonic Dystrophy Type 1 (DM1)
October 6, 2025

Dyne Therapeutics Announces Additional One-Year Clinical Data Demonstrating Functional Improvement from Phase 1/2 ACHIEVE Trial of Zeleciment Basivarsen (DYNE-101) for Myotonic Dystrophy Type 1 (DM1)

Indeterminate GlobeNewswire
FOBI AI ANNOUNCES LAUNCH OF “FOBI AI 3.0” — STRATEGY. ARCHITECTURE. EXECUTION.
October 6, 2025

FOBI AI ANNOUNCES LAUNCH OF “FOBI AI 3.0” — STRATEGY. ARCHITECTURE. EXECUTION.

Indeterminate GlobeNewswire
DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq
October 6, 2025

DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq

Indeterminate GlobeNewswire
DBV Technologies annonce un placement d’ADS pour un montant d’environ 30 millions de Dollars US dans le cadre de son programme At-The-Market (ATM) sur le Nasdaq
October 6, 2025

DBV Technologies annonce un placement d’ADS pour un montant d’environ 30 millions de Dollars US dans le cadre de son programme At-The-Market (ATM) sur le Nasdaq

Indeterminate GlobeNewswire
NowVertical Retires Debentures in Full, Strengthening Balance Sheet
October 6, 2025

NowVertical Retires Debentures in Full, Strengthening Balance Sheet

Indeterminate GlobeNewswire
Eisai and Biogen Announce U.S. Availability of LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection Maintenance Dose for Treatment of Early Alzheimer’s Disease
October 6, 2025

Eisai and Biogen Announce U.S. Availability of LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection Maintenance Dose for Treatment of Early Alzheimer’s Disease

Indeterminate GlobeNewswire
Biomea Fusion Announces Proposed Public Offering of Securities
October 6, 2025

Biomea Fusion Announces Proposed Public Offering of Securities

Indeterminate GlobeNewswire
Serina Therapeutics Draws First $5 Million Funding Tranche to Support Registrational Trial of SER-252 in Parkinson’s Disease
October 6, 2025

Serina Therapeutics Draws First $5 Million Funding Tranche to Support Registrational Trial of SER-252 in Parkinson’s Disease

Indeterminate GlobeNewswire
Gaming Arts LLC Announces Partnership with Inspired Entertainment to Bring Online Titles to North and South American Land-Based Markets
October 6, 2025

Gaming Arts LLC Announces Partnership with Inspired Entertainment to Bring Online Titles to North and South American Land-Based Markets

Indeterminate GlobeNewswire
SAIC to Acquire SilverEdge Government Solutions
October 6, 2025

SAIC to Acquire SilverEdge Government Solutions

Indeterminate GlobeNewswire
Sprout Social to Announce Third Quarter 2025 Financial Results on November 5, 2025
October 6, 2025

Sprout Social to Announce Third Quarter 2025 Financial Results on November 5, 2025

Indeterminate GlobeNewswire
Acquisition of Verona by MSD Approved by the High Court of Justice of England and Wales
October 6, 2025

Acquisition of Verona by MSD Approved by the High Court of Justice of England and Wales

Indeterminate GlobeNewswire
Senseonics Announces Preliminary Unaudited Revenue for Third Quarter 2025 and Provides Business Update
October 6, 2025

Senseonics Announces Preliminary Unaudited Revenue for Third Quarter 2025 and Provides Business Update

Indeterminate GlobeNewswire
Immix Biopharma to Present Abstract at the upcoming ASH 2025 Annual Meeting
October 6, 2025

Immix Biopharma to Present Abstract at the upcoming ASH 2025 Annual Meeting

Indeterminate GlobeNewswire
Crinetics Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 6, 2025
October 6, 2025

Crinetics Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 6, 2025

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions